Liliana M. Finkielsztein
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Studies of 4-arylthiazolylhydrazones derived from 1-indanones as Trypanosoma cruzi squalene epoxidase inhibitors by molecular simulations.
Journal: Organic & biomolecular chemistry
Published: October 26, 2018
N4 -aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment.
Journal: Journal of cellular physiology
Published: August 08, 2017
Synthesis, antiviral evaluation and molecular docking studies of N4-aryl substituted/unsubstituted thiosemicarbazones derived from 1-indanones as potent anti-bovine viral diarrhea virus agents.
Journal: Bioorganic & medicinal chemistry
Published: March 02, 2017
QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 26, 2015
In silico study of structural and geometrical requirements of natural sesquiterpene lactones with trypanocidal activity.
Journal: Mini reviews in medicinal chemistry
Published: November 20, 2012
Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Journal: Journal of inorganic biochemistry
Published: July 17, 2012
Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
Journal: European journal of medicinal chemistry
Published: February 17, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026